Hologic pockets CE mark for contrast biopsy software
The receipt of a CE mark in Europe for Affirm follows the software gaining US market clearance from the FDA in October 2020.
Hosted on MSN1d
Do Options Traders Know Something About Hologic (HOLX) Stock We Don't?
Investors in Hologic, Inc. HOLX need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $40.00 Call had some of the highest implied ...
Hologic obtains CE Mark for Affirm Contrast Biopsy Software
Hologic (HOLX) announced that its Affirm Contrast Biopsy Software, which combines contrast-enhanced diagnostic capabilities with accurate ...
BD business separation could allow competitors to rise in IVD test markets
Competitors could acquire these strong segments to boost their own sales, as they earned more than $3 billion in the fiscal ...
New Mexico Educational Retirement Board Sells 400 Shares of Hologic, Inc. (NASDAQ:HOLX)
New Mexico Educational Retirement Board cut its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.5% in ...
Hologic Inc. stock outperforms competitors on strong trading day
Hologic Inc. closed 24.50% short of its 52-week high of $84.67, which the company reached on August 9th.
Hologic announces FDA clearance of Aptima SARS-CoV-2 assay
Hologic (HOLX) announced that the FDA has granted 510(k) clearance for the company’s Aptima SARS-CoV-2 assay, which was first granted Emergency ...